Study of significance of elevated maternal serum β-human chorionic gonadotropin (β-hCG) level in 16 to 20 weeks pregnant women as predictor of hypertensive disorder of pregnancy
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20184537Keywords:
β-hCG, Early second trimester, Hypertensive disorder of pregnancyAbstract
Background: Hypertensive disorder of pregnancy affects both mother and fetus, leading their high morbidity and mortality and a major killer of women in developing country. The etiologic of preeclampsia is still not clear. It seems that placenta plays main role in path-physiology of preeclampsia, but there is strict relationship between hypertensive disorder of pregnancy and elevated β-hCG level, indicating there should be an abnormal placental secretary function in patients with severe preeclampsia.
Methods: 245 patients were recruited from our institute (OPD) and Prospective analytical study was started with 16-20 weeks pregnant women. Cases were subjected to detailed history and thorough physical examination including baseline blood pressure. β-hCG measurement was done between 16-20 weeks and cases were followed at regular interval for the development of hypertensive disorder of pregnancy. Statistical testing was conducted with appropriate tests.
Results: Total 245 women were enrolled in the study, only 208 were followed till delivery, 24 were developed hypertension. On analysis of data, maximum cases were younger, primigravida and of lower class. β-hCG levels (Mean ± SD) were also significantly higher (30100±16250 V/S 74700±23790; p<0.001) in subjects who later developed hypertension. Cut off value of β-hCG was 45755 mIU/ml, and analysis establishes validity of β-hCG as predictor of hypertensive disorder of pregnancy with sensitivity, specificity, positive and negative predictive value for β hCG were 87.5, 83.2, 70.4 and 83.7% respectively.
Conclusions: Present study shows that elevated serum β-hCG in early second trimester can be considered as predictor of subsequent hypertensive disorder of pregnancy.
References
Wolde Z, Segni H, Woldie M. Hypertentive disorders of pregnancy in Jimma university specialized hospital. Ethiop J Health Sci. 2011; 21(3):147-54.
Bardale RV, Dixit PG. Pregnancy-related death: A three-year retrospective study. J Indian Acad Forensic Med. 2010;32(1):15-18.
Maria B Maternal mortality. Avoidable obstetrical complication. J Gynaecol Obstet Biol Reprod. (Paris) 2001;30(6):23-32.
Kang A, Struben H. Pre-eclampsia screening in first trimester.J Gynaecol Obstet. 2008;65(11):663-6.
Duckitt K, Harrington D. Risk factor for preeclampsia at antenatal booking: systemic review of controlled studies. BMJ 2005;330(7491):565-6.
González AL1, Ulloa Galván G, Alpuche G, Romero Arauz JF. Risk factor for pre-elampsia ; multivariate analysis .J Gynaecol Obstet Mex. 2000;68:357-62.
Kashanian M, Baradaran HR, Bahasadri S, Alimohammadi R. Risk Factors for Pre-Eclampsia: A Study in Tehran, Iran. Arch Iran Med. 2011;14 (6):412-5.
Lambert-Messerlian GM, Silver HM, Petraglia F, Luisi S, Pezzani I, Maybruck WM, et al. Second trimester level of maternal human chorionic gonadotropin and inhibin-a as a predictor preeclampsia in the third trimester of pregnancy. J soc. Gynaecol Invest. 2000;7(3):170-4.
Lindheimer MD, Conrad K, Karumanchi SA. Renal physiology and disease in pregnancy. In Alpern RJ, Hebert SC (eds): Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology, 4th ed. New York, Elsevier, 2008a, p 2339.
Conde-Agudelo A, Romero R, Roberts JM. Tests to predict preeclampsia. In Taylor RN, Roberts JM, Cunningham FG (eds): Chesley’s Hypertensive Disorders in Pregnancy, 4th ed. Amsterdam, Academic Press, 2014.
Odibo AO, Rada CC, Cahill AG, Goetzinger KR, Tuuli MG, Odibo L. First-trimester serum soluble fms- like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia. J Perinatal.2013; 2013;33(9):670.
International journal of Medicine and Applied sciences, ISSN 2320-3137. Department of Biochemistry, Amla institute of Medical Science, Thrissur Kerala.
Chowdhary H, Khurshid R, Praveen S, Yousuf S, Tali SH, Shah ZA. Utility of second trimester β-hCG levels in prediction of gestational hypertension: a prospective cohort study. Int J Reprod Contracept Obstet Gynecol. 2017;6 (3):1040-4.
Mallick MP, Ray S, Medhi R, Bisai S. Elevated serum β-hCG and dyslipidemia in second trimester as predictors of subsequent Pregnancy Induced Hypertension. Bangladesh Med Res Counc Bull. 2015; 40(3):97-101.
Priya NK. Estimation of raised mid trimester β-hCG as predictor of PIH. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS).2016; 15(12):40-43.
Yadav K, Aggarwal S, Verma K. Serum β-hCG and lipid profile in early second trimester as predictors of pregnancy induced hypertension. J Obstet Gynaecol India. 2014;64(3):169-74.
Uddin AW, Nessa S, Chowdhury S, Banu M. Hypertensive disorders of pregnancy and it’s outcome in a tertiary care hospital. J Armed Forces Med College, Bangla. 2015;9(2):38-4
Kaur G, Jain V, Mehta S, Himani S. Prediction of hypertensive disorder of pregnancy by Maternal Serum β-hCG Levels in the Second Trimester (13–20 Weeks) of Pregnancy. J Obstet Gynecol India. 2012; 62(1):32-4.
Moslemizadeh N, Moslemizadeh KY. Serum β-hCG levels in diagnosis and management of preeclampsia. J Med Sci. 2008;8(8):722-7.
Silva LM, Coolman M, Steegers EA, Jaddoe VW, Moll HA, Hofman A, et al; low socioeconomic status is a risk factor for preeclampsia: th generation r study. J Hypertens. 2008;26(6):1200-8.
Basirat Z, Barat S, Hajiahmadi M. Serum beta human chorionic gonadotropin levels and preeclampsia. Saudi Med. J. 2006;27(7):1001-4.
Tebeu PM, Foumanae P, Mbu R, Fosso G, Biyaga PT, Fomulu JN. Risk factor for hypertensive disorder in pregnancy, Report from the Maroua Regional Hospital, Cameroon. J Repord Infertil. 2011; 12(3):227-34.
Sivakumar S, Vishnu Bhat B, Badhe BA. Effect of pregnancy induced hypertension on mothers and their babies. Indian J Pediatr. 2007;74(7):623-5.
Begum Z, Are I, Tanira S, Keya KA. The association between serum beta human chorionic gonadotropin and preeclampsia. J Dhaka Med Coll. 2015;23(1): 89-93.
Mamatha S, Singh S, Sujatha MS, Mahesh M. Comparative study of lipid profile in normotensive and hypertensive pregnant women. Int j sci stud. 2015;3(7):222-5.
Dayal M, Gupta P, Varma M, Ghose UK, Bhargava A. Evaluate the variations and potential clinical use of second trimester serum markers as predictor of preeclampsia. J Obstet Gynecol India. 2011; 61(1):38-41.
Choudhury KM, Das M, Ghosh S, Bhattacharya D, Ghosh TK. Value of serum β-hCG in pathogenesis of pre-eclampsia. J Clin Gynecol Obstet. 2012;1(4-5):71-5.
Kumari P, Sharma SN, Kumar S, Kumar MA. A comparative study of blood pressure in normal and pregnancy induced hypertensive cases for early diagnosis of hypertensive disorders in a tertiary care hospital. Int J Sci Stud.2014;2(3):33-7.
Vidyabati RK, Hijam D, Singh NK, Singh WG. Serum β-hCG and lipid profile in second trimester as predictors of pregnancy induced hypertension. J Obstet Gynecol India. 2010;60(1):44-50.
Pairu J, Bharathi KN, George K. Maternal and perinatal outcome in pregnancy induced hypertension and preeclampsia. Int J Reprod Contracept Obstet Gynecol. 2017;5(7):2166-70.
Fatemeh T, Marziyeh G, Nayereh G, Anahita G, Samira T. Maternal and perinatal outcome in nulliparious women complicated with pregnancy hypertension. J Pak Med Assoc. 2010;60(9):707.
Revankar VM, Narmada L. Assessment of serum β‐hCG and lipid profile in early second trimester as predictors of hypertensive disorders of pregnancy. Int J Gynecol Obstet. 2017;138(3):331-4.
Soundararajan P, Muthuramu P, Veerapandi M, Mariyappan R. Serum beta human chorionic gonadotropin and lipid profile in early second trimester (14-20 weeks) is a predictor of pregnancy-induced hypertension. Int J Reprod Contracept Obstet Gynecol. 2016;5(9):3011-6.
